FDA Law Blog
AUGUST 4, 2023
Houck — Anabolic steroids that include testosterone, methyltestosterone, nandrolone decanoate and oxandrolone are schedule III controlled substances with currently accepted medical uses in the U.S. Other anabolic steroids are approved only for use in veterinary medicine. at 50,040 codified at 21 C.F.R. 21 U.S.C. §§ 842(c)(1)(C) and (D).
FDA Law Blog
APRIL 22, 2024
Milgram’s predecessors, and Directors of National Drug Policy urging not to reschedule; the January 2004 letter Democratic state attorneys general pushing for rescheduling to schedule III; and the January 2024 letter from Democratic senators requesting descheduling altogether. On a final note, as a signatory to the Single Convention, U.S.
FDA Law Blog
MAY 7, 2025
Gonzalez There has been increased enforcement against medical device companies that engage in the pervasive practice of paying third party sales agents based on their volume of sales. In that decision, a medical laboratory paid Marchetti percentage-based compensation for successful referrals of Medicare patients to the laboratory.
Expert insights. Personalized for you.
52 
Let's personalize your content